{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:33:59Z","timestamp":1780320839826,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Geriatric Nursing"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.gerinurse.2025.103769","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T08:33:23Z","timestamp":1766565203000},"page":"103769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Examining pharmacological and demographic factors among male and female alzheimer\u2019s disease patients diagnosed with attention concentration disorder and cognitive communication disorder"],"prefix":"10.1016","volume":"68","author":[{"given":"Ashna","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidadi L.","family":"Agbomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adebobola I","family":"Nathaniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel I","family":"Nathaniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie Theriot","family":"Roley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0954-5050","authenticated-orcid":false,"given":"Thomas I.","family":"Nathaniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gerinurse.2025.103769_bib0001","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0002","doi-asserted-by":"crossref","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in Alzheimer Disease: an update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J Cent Nerv Syst Dis"},{"issue":"5","key":"10.1016\/j.gerinurse.2025.103769_bib0003","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"2024 Alzheimer's disease facts and figures","volume":"20","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.gerinurse.2025.103769_bib0004","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/alz.12737","article-title":"Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials","volume":"19","author":"Langbaum","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0005","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1044\/2023_PERSP-23-00012","article-title":"Cognitive-communication disorders and neurodisability in the Criminal Justice System: emerging roles, responsibilities, and opportunities for speech-language pathologists","volume":"8","author":"Albin","year":"2023","journal-title":"Perspect ASHA Spec Interest Groups"},{"issue":"5","key":"10.1016\/j.gerinurse.2025.103769_bib0006","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006148","article-title":"The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment","volume":"2","author":"Tarawneh","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5","key":"10.1016\/j.gerinurse.2025.103769_bib0007","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","article-title":"Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment","volume":"28","author":"McCutcheon","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcomdis.2023.106316","article-title":"Prevalence and sociodemographic characteristics of US community-dwelling older adults with communication disabilities, using the national health and aging trends survey","volume":"102","author":"Oshita","year":"2023","journal-title":"J Commun Disord"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0009","series-title":"Attention Deficit Hyperactivity Disorder. StatPearls","author":"Magnus","year":"2025"},{"issue":"5","key":"10.1016\/j.gerinurse.2025.103769_bib0010","first-page":"467","article-title":"ADHD diagnostic trends: increased recognition or overdiagnosis?","volume":"119","author":"Abdelnour","year":"2022","journal-title":"Mo Med"},{"issue":"4","key":"10.1016\/j.gerinurse.2025.103769_bib0011","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3233\/JAD-180141","article-title":"Differences between women and men in incidence rates of dementia and Alzheimer's Disease","volume":"64","author":"Beam","year":"2018","journal-title":"J Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.gerinurse.2025.103769_bib0012","doi-asserted-by":"crossref","first-page":"437","DOI":"10.31887\/DCNS.2016.18.4\/cepperson","article-title":"Considering sex and gender in Alzheimer disease and other dementias","volume":"18","author":"Podcasy","year":"2016","journal-title":"Dialogues Clin Neurosci"},{"issue":"1","key":"10.1016\/j.gerinurse.2025.103769_bib0013","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1212\/CON.0000000000000700","article-title":"Late-onset Alzheimer Disease","volume":"25","author":"Rabinovici","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2020.100879","article-title":"Sex and gender differences in cognitive and brain reserve: implications for Alzheimer's disease in women","volume":"60","author":"Subramaniapillai","year":"2021","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0015","first-page":"89","article-title":"Alcohol-related cognitive impairments: an overview of how alcoholism may affect the workings of the brain","volume":"19","author":"Evert","year":"1995","journal-title":"Alcohol Health Res World"},{"issue":"1","key":"10.1016\/j.gerinurse.2025.103769_bib0016","doi-asserted-by":"crossref","first-page":"03","DOI":"10.35946\/arcr.v44.1.03","article-title":"Alcohol use disorder and dementia: a review","volume":"44","author":"Zahr","year":"2024","journal-title":"Alcohol Res"},{"issue":"21","key":"10.1016\/j.gerinurse.2025.103769_bib0017","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1021\/acschemneuro.4c00339","article-title":"Alzheimer's Disease: exploring the landscape of cognitive decline","volume":"15","author":"Tenchov","year":"2024","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0018","first-page":"112","article-title":"Later life depression as risk factor for developing dementia: epidemiological evidence, predictive models, preventive strategies and future trends","author":"Piras","year":"2021","journal-title":"Minerva Med"},{"issue":"10","key":"10.1016\/j.gerinurse.2025.103769_bib0019","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.38088","article-title":"Adult Attention-Deficit\/Hyperactivity disorder and the risk of dementia","volume":"6","author":"Levine","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"Pt 3","key":"10.1016\/j.gerinurse.2025.103769_bib0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/brain\/122.3.383","article-title":"Attention and executive deficits in Alzheimer's disease. A critical review","volume":"122","author":"Perry","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1052330","article-title":"The role of ethnicity, biological sex, and psychotropic agents in early and late onset Alzheimer's disease","volume":"14","author":"Miller","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0023","series-title":"Selective serotonin reuptake inhibitors. StatPearls","author":"Chu","year":"2025"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahr.2022.100096","article-title":"Gender differences in Parkinson's disease with dementia and dementia with lewy bodies","volume":"2","author":"Agbomi","year":"2022","journal-title":"Aging Health Res"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0025","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3389\/fpsyt.2018.00702","article-title":"Antipsychotic drug responsiveness and dopamine receptor signaling; old players and new prospects","volume":"9","author":"Rampino","year":"2018","journal-title":"Front Psychiatry"},{"issue":"2","key":"10.1016\/j.gerinurse.2025.103769_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12020160","article-title":"Gender differences in demographic and pharmacological factors in patients diagnosed with late-onset of Alzheimer's disease","volume":"12","author":"Bailey-Taylor","year":"2022","journal-title":"Brain Sci"},{"issue":"236","key":"10.1016\/j.gerinurse.2025.103769_bib0027","doi-asserted-by":"crossref","first-page":"236re4","DOI":"10.1126\/scitranslmed.3008169","article-title":"An antidepressant decreases CSF a\u03b2 production in healthy individuals and in transgenic AD mice","volume":"6","author":"Sheline","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0028","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.gerinurse.2024.11.001","article-title":"Risk factors of male and female Alzheimer's disease patients with neuropsychiatric symptoms","volume":"61","author":"Broughton","year":"2025","journal-title":"Geriatr Nurs (Minneap)"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2019.04.009","article-title":"Neuroprotective effects of the second generation antipsychotics","volume":"208","author":"Chen","year":"2019","journal-title":"Schizophr Res"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2022.828782","article-title":"Sex differences in demographic and pharmacological factors in Alzheimer patients with dementia and cognitive impairments","volume":"16","author":"Coker-Ayo","year":"2022","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108748","article-title":"Dual inhibition of butyrylcholinesterase and p38\u03b1 mitogen-activated protein kinase: a new approach for the treatment of Alzheimer's disease","volume":"264","author":"Ferjan\u010di\u010d Benetik","year":"2024","journal-title":"Pharmacol. Ther"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0032","article-title":"Sex differences in risk factors for Alzheimer dementia encephalopathy patients","volume":"4","author":"O'Brien","year":"2025","journal-title":"Front Dement"},{"issue":"6","key":"10.1016\/j.gerinurse.2025.103769_bib0033","article-title":"Donepezil for dementia due to Alzheimer's disease","volume":"6","author":"Birks","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.gerinurse.2025.103769_bib0034","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12888-023-04552-y","article-title":"Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia","volume":"23","author":"Haddad","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/frdem.2023.1137856","article-title":"Differences in pharmacologic and demographic factors in male and female patients with vascular dementia, Alzheimer's disease, and mixed vascular dementia","volume":"2","author":"Stanley","year":"2023","journal-title":"Front Dement"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0036","doi-asserted-by":"crossref","unstructured":"Marcinkowska M, \u015aniecikowska J, Fajkis N, Pa\u015bko P, Franczyk W, Ko\u0142aczkowski M Management of dementia-related psychosis, agitation and aggression: a review of the pharmacology and clinical effects of potential drug candidates. CNS Drugs. Mar 2020;34(3):243\u2013268. doi:10.1007\/s40263-020-00707-7","DOI":"10.1007\/s40263-020-00707-7"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0037","doi-asserted-by":"crossref","first-page":"e1566","DOI":"10.1136\/bmj.e1566","article-title":"Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial","volume":"344","author":"Bergh","year":"2012","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.gerinurse.2025.103769_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.aggp.2025.100202","article-title":"Sociodemographic factors and psychotropic medication use among Alzheimer\u2019s dementia patients diagnosed with normal pressure hydrocephalus and mild cognitive impairment: sex variation in a retrospective cohort analysis","volume":"2","author":"Babalola","year":"2025","journal-title":"Arch Gerontol Geriatr Plus"},{"issue":"5","key":"10.1016\/j.gerinurse.2025.103769_bib0039","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1176\/appi.ajp.2016.15020248","article-title":"Effects of Citalopram on neuropsychiatric symptoms in Alzheimer\u2019s dementia: evidence from the CitAD study","volume":"173","author":"Leonpacher","year":"2016","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fgwh.2025.1601375","article-title":"Sex differences in clinical risk factors for Alzheimer's dementia patients with early-onset and late-onset","volume":"6","author":"Faulstich","year":"2025","journal-title":"Front Glob Womens Health"},{"issue":"7","key":"10.1016\/j.gerinurse.2025.103769_bib0041","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jama.2014.93","article-title":"Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial","volume":"311","author":"Porsteinsson","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.gerinurse.2025.103769_bib0042","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1192\/bjo.2020.107","article-title":"Effect of acute citalopram on self-referential emotional processing and social cognition in healthy volunteers","volume":"6","author":"Hobbs","year":"2020","journal-title":"BJPsych Open"},{"issue":"3","key":"10.1016\/j.gerinurse.2025.103769_bib0043","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","article-title":"Memantine treatment in patients with moderate to severe alzheimer disease already receiving DonepezilA randomized controlled trial","volume":"291","author":"Tariot","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0044","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.curtheres.2017.07.001","article-title":"Can a selective serotonin reuptake inhibitor act as a glutamatergic modulator?","volume":"87","author":"Frizzo","year":"2017","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.117913","article-title":"Effects of SSRI treatment on GABA and glutamate levels in an associative relearning paradigm","volume":"232","author":"Spurny","year":"2021","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.gerinurse.2025.103769_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.aggp.2025.100184","article-title":"Sex differences in risk factors associated with Alzheimer\u2019s dementia patients with irritability and anger","volume":"2","author":"Brewer","year":"2025","journal-title":"Arch Gerontol Geriatr Plus"},{"issue":"8","key":"10.1016\/j.gerinurse.2025.103769_bib0047","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2174\/1570159X15666170413115754","article-title":"Aripiprazole, A drug that displays partial agonism and functional selectivity","volume":"15","author":"Tuplin","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137410","article-title":"Aripiprazole combined with nerve growth factor improves cognitive function in mice with schizophrenia model","volume":"812","author":"Lu","year":"2023","journal-title":"Neurosci. Lett"},{"issue":"3","key":"10.1016\/j.gerinurse.2025.103769_bib0049","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"48","author":"Soldin","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0050","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fphar.2015.00122","article-title":"Gender differences in pharmacokinetics and pharmacodynamics of methadone substitution therapy","volume":"6","author":"Graziani","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.931536","article-title":"Normal aging induces changes in the brain and neurodegeneration progress: review of the structural, biochemical, metabolic, cellular, and molecular changes","volume":"14","author":"Lee","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"10.1016\/j.gerinurse.2025.103769_bib0052","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1002\/alz.13612","article-title":"Mapping racial and ethnic healthcare disparities for persons living with dementia: a scoping review","volume":"20","author":"Hinton","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.gerinurse.2025.103769_bib0053","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1037\/a0032113","article-title":"Less drinking, yet more problems: understanding African American drinking and related problems","volume":"140","author":"Zapolski","year":"2014","journal-title":"Psychol Bull"},{"issue":"1","key":"10.1016\/j.gerinurse.2025.103769_bib0054","first-page":"42","article-title":"Alcohol dependence and health care utilization in African Americans","volume":"105","author":"Marshall","year":"2013","journal-title":"J Natl Med Assoc"},{"issue":"5","key":"10.1016\/j.gerinurse.2025.103769_bib0055","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1176\/appi.ps.201300188","article-title":"Disparities in the use and quality of alcohol treatment services and some proposed solutions to narrow the gap","volume":"65","author":"Mulia","year":"2014","journal-title":"Psychiatr Serv"},{"issue":"1","key":"10.1016\/j.gerinurse.2025.103769_bib0056","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/ADR-210061","article-title":"Neuroprotective effects of cholinesterase inhibitors: current scenario in therapies for Alzheimer's disease and future perspectives","volume":"6","author":"Moreira","year":"2022","journal-title":"J Alzheimers Dis Rep"},{"issue":"2","key":"10.1016\/j.gerinurse.2025.103769_bib0057","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/ph17020167","article-title":"Risperidone decreases expression of serotonin receptor-2A (5-HT2A) and serotonin transporter (SERT) but not dopamine receptors and dopamine transporter (DAT) in PBMCs from patients with schizophrenia","volume":"17","author":"Alvarez-Herrera","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.gerinurse.2025.103769_bib0058","series-title":"StatPearls","article-title":"Cholinergic crisis","author":"Adeyinka","year":"2025"}],"container-title":["Geriatric Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197457225006123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197457225006123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:42:25Z","timestamp":1774960945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197457225006123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":58,"alternative-id":["S0197457225006123"],"URL":"https:\/\/doi.org\/10.1016\/j.gerinurse.2025.103769","relation":{},"ISSN":["0197-4572"],"issn-type":[{"value":"0197-4572","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining pharmacological and demographic factors among male and female alzheimer\u2019s disease patients diagnosed with attention concentration disorder and cognitive communication disorder","name":"articletitle","label":"Article Title"},{"value":"Geriatric Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gerinurse.2025.103769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103769"}}